| BLT Appendix 4D and Half Year Report |
| 25/02/19 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 31/01/19 | PRICE SENSITIVE | | Share |
|
| BLT Benitec Provides Update on BB-401 Cancer Treatment Program |
| 21/12/18 | PRICE SENSITIVE | | Share |
|
| BLT Chairman's Presentation to Shareholders |
| 08/11/18 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 29/10/18 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4E and 2018 Annual Report |
| 30/08/18 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 31/07/18 | PRICE SENSITIVE | | Share |
|
| BLT Benitec Announces Global Licensing Agreement with Axovant |
| 09/07/18 | PRICE SENSITIVE | 262KB | Share |
|
| BLT Trading Halt |
| 09/07/18 | PRICE SENSITIVE | 828.04KB | Share |
|
| BLT EARNINGS REPORT FISCAL THIRD QUARTER 2018 |
| 31/05/18 | PRICE SENSITIVE | 273.2KB | Share |
|
| BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2018 |
| 31/05/18 | PRICE SENSITIVE | 552.56KB | Share |
|
| BLT PHASE 2 ONCOLOGY STUDY RUSSIAN APPROVAL |
| 24/05/18 | PRICE SENSITIVE | 243.3KB | Share |
|
| BLT ENTITLEMENT OFFER AND PLACEMENT |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| BLT ENTITLEMENT OFFER BOOKLET |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| BLT Trading Halt |
| 26/04/18 | PRICE SENSITIVE | | Share |
|
| BLT CLINICAL PROGRAM UPDATE |
| 24/04/18 | PRICE SENSITIVE | | Share |
|
| BLT PHASE 2 ONCOLOGY STUDY LAUNCHED |
| 05/03/18 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4D and Half Year Report |
| 22/02/18 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/01/18 | PRICE SENSITIVE | | Share |
|
| BLT RESEARCH & DEVELOPMENT GRANT RECEIVED |
| 23/01/18 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC RECEIVES US ORPHAN DESIGNATION FOR BB-301 |
| 15/01/18 | PRICE SENSITIVE | | Share |
|
| BLT Earnings Report First Fiscal Quarter 2018 |
| 29/11/17 | PRICE SENSITIVE | | Share |
|
| BLT Interim Report 3 Months to 30 September 2017 |
| 29/11/17 | PRICE SENSITIVE | | Share |
|
| BLT OPMD Orphan Disease Program Update |
| 27/11/17 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/10/17 | PRICE SENSITIVE | | Share |
|
| BLT Response to ASX Query Letter |
| 23/10/17 | PRICE SENSITIVE | | Share |
|
| BLT US PATENT GRANTED FOR HEPATITIS B PROGRAM |
| 18/10/17 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4E and Annual Report |
| 29/08/17 | PRICE SENSITIVE | | Share |
|
| BLT OPMD ORPHAN DISEASE PROGRAM ADVANCEMENT |
| 08/08/17 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 27/07/17 | PRICE SENSITIVE | | Share |
|
| BLT RESEARCH & DEVELOPMENT GRANT RECEIVED |
| 09/06/17 | PRICE SENSITIVE | | Share |
|
| BLT SEC SHELF REGISTRATION |
| 02/06/17 | PRICE SENSITIVE | | Share |
|
| BLT INTERIM REPORT NINE MONTHS TO 31 MARCH 2017 |
| 30/05/17 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 27/04/17 | PRICE SENSITIVE | | Share |
|
| BLT OPMD KEY DATA PUBLISHED IN NATURE |
| 03/04/17 | PRICE SENSITIVE | | Share |
|
| BLT RESEARCH & DEVELOPMENT GRANT RECEIVED |
| 24/03/17 | PRICE SENSITIVE | | Share |
|
| BLT CLOSING OF NANT SECOND TRANCHE PLACEMENT |
| 13/03/17 | PRICE SENSITIVE | | Share |
|
| BLT AGREEMENT ON NANT SECOND TRANCHE PLACEMENT |
| 08/03/17 | PRICE SENSITIVE | | Share |
|
| BLT Half Yearly Report and Accounts |
| 22/02/17 | PRICE SENSITIVE | | Share |
|
| BLT UPDATE ON OCULAR PROGRAM AND PRESENTATION |
| 02/02/17 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 31/01/17 | PRICE SENSITIVE | | Share |
|
| BLT ONCOLOGY PROGRAM INITIATED WITH NANT |
| 30/01/17 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC ANNOUNCES EU ODD FOR BB301 |
| 17/01/17 | PRICE SENSITIVE | | Share |
|
| BLT Cancer program in-licensed from Nant |
| 23/12/16 | PRICE SENSITIVE | | Share |
|
| BLT MARKET UPDATE |
| 22/12/16 | PRICE SENSITIVE | | Share |
|
| BLT Benitec announces pivotal HBV in vivo data |
| 21/12/16 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly-BLT.AX |
| 28/10/16 | PRICE SENSITIVE | | Share |
|
| BLT Strateigc engagement with NantVentures-BLT.AX |
| 24/10/16 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX |
| 16/09/16 | PRICE SENSITIVE | | Share |
|
| BLT Preliminary Final Report-BLT.AX |
| 30/08/16 | PRICE SENSITIVE | | Share |
|
| BLT RESTRUCTURING OF SENIOR EXECUTIVE TEAM-BLT.AX |
| 10/08/16 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly-BLT.AX |
| 28/07/16 | PRICE SENSITIVE | | Share |
|
| BLT Response to ASX price query-BLT.AX |
| 20/07/16 | PRICE SENSITIVE | | Share |
|
| BLT FEDERAL R&D GRANT RECEIVED-BLT.AX |
| 16/06/16 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly-BLT.AX |
| 29/04/16 | PRICE SENSITIVE | | Share |
|
| BLT POSITIVE HBV IN VIVO DATA |
| 08/03/16 | PRICE SENSITIVE | | Share |
|
| BLT Half Yearly Report and Accounts |
| 26/02/16 | PRICE SENSITIVE | | Share |
|
| BLT UPDATE ON HCV CLINICAL TRIAL |
| 26/02/16 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 29/01/16 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC CFO APPOINTED INTERIM CEO |
| 09/12/15 | PRICE SENSITIVE | | Share |
|
| BLT HEP B PRECLINICAL RESULTS |
| 07/12/15 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/10/15 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC ABSTRACT ACCEPTED FOR AASLD MEETING |
| 22/10/15 | PRICE SENSITIVE | | Share |
|
| BLT LONZA AGREEMENT FOR SCALABLE AAV MANUFACTURING |
| 07/10/15 | PRICE SENSITIVE | | Share |
|
| BLT App 4E / Full Year Statutory Accounts |
| 31/08/15 | PRICE SENSITIVE | | Share |
|
| BLT US IPO PRICED AND NASDAQ LISTING |
| 19/08/15 | PRICE SENSITIVE | | Share |
|
| BLT Trading Halt |
| 18/08/15 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/07/15 | PRICE SENSITIVE | | Share |
|
| BLT ACQUISITION OF HEPATITIS B PROGRAM |
| 09/07/15 | PRICE SENSITIVE | | Share |
|
| BLT DEVELOPMENT OF OPMD THERAPEUTIC COLLABORATION |
| 03/07/15 | PRICE SENSITIVE | | Share |
|
| BLT 6TH PATIENT DOSED IN HEPATITIS TRIAL |
| 25/06/15 | PRICE SENSITIVE | | Share |
|
| BLT PLANS FOR IPO IN US WITH NASDAQ LISTING |
| 23/06/15 | PRICE SENSITIVE | | Share |
|
| BLT RENEURON CELLULAR THERAPIES COLLABORATION |
| 22/06/15 | PRICE SENSITIVE | | Share |
|
| BLT MANUFACTURING UPDATE |
| 25/05/15 | PRICE SENSITIVE | | Share |
|
| BLT PATENT UPDATE |
| 18/05/15 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 29/04/15 | PRICE SENSITIVE | | Share |
|
| BLT HEPATITIS C TRIAL UPDATE |
| 29/04/15 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC LICENSE WITH ASKLEPIOS |
| 17/04/15 | PRICE SENSITIVE | | Share |
|
| BLT UPDATE ON TT034 TRIAL |
| 07/04/15 | PRICE SENSITIVE | | Share |
|
| BLT FOURTH PATIENT DOSED IN HEPATITIS C TRIAL |
| 11/03/15 | PRICE SENSITIVE | | Share |
|
| BLT FEDERAL R&D GRANT RECEIVED |
| 03/03/15 | PRICE SENSITIVE | | Share |
|
| BLT UPDATE ON TT034 TRIAL FOR HEPATITIS C |
| 03/03/15 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC LICENSED RNAI PATENT SUCCEEDS IN EUROPE |
| 02/03/15 | PRICE SENSITIVE | | Share |
|
| BLT Half Yearly Report and Accounts |
| 26/02/15 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/01/15 | PRICE SENSITIVE | | Share |
|
| BLT RESEARCH SUPPORTS ADDITIONAL CANCER INDICATIONS |
| 08/01/15 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC ADVANCES HEPATITIS C CLINICAL TRIAL |
| 07/01/15 | PRICE SENSITIVE | | Share |
|
| BLT DRUG RESISTANCE IN LUNG CANCER PROGRAM |
| 10/12/14 | PRICE SENSITIVE | | Share |
|
| BLT SECOND PATIENT DOSED IN TT034 TRIAL |
| 13/11/14 | PRICE SENSITIVE | | Share |
|
| BLT Response to ASX price query |
| 11/11/14 | PRICE SENSITIVE | | Share |
|
| BLT PAIN LICENSE AND TT034 RESPONSE |
| 03/11/14 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 31/10/14 | PRICE SENSITIVE | | Share |
|
| BLT HCV TT-034 TRIAL - UPDATE ON PROGRESS |
| 30/10/14 | PRICE SENSITIVE | | Share |
|
| BLT BENITEC APPEALS GRAHAM PATENT REVOCATION IN EUROPE |
| 22/09/14 | PRICE SENSITIVE | | Share |
|
| BLT HCV TRIAL UPDATE |
| 29/08/14 | PRICE SENSITIVE | | Share |
|
| BLT Preliminary Final Report |
| 22/08/14 | PRICE SENSITIVE | | Share |
|
| BLT Response to ASX price query |
| 18/08/14 | PRICE SENSITIVE | | Share |
|
| BLT Appendix 4C - quarterly |
| 30/07/14 | PRICE SENSITIVE | | Share |
|
| BLT HCV TRIAL UPDATE |
| 21/07/14 | PRICE SENSITIVE | | Share |
|
